Skip to content
healthcare.dev

Docetaxel

NDC 45963-734, Docetaxel, injection, solution, concentrate, from Actavis Pharma, Inc..

Product NDC
45963-734
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA203551
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45963-734 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOCETAXEL20 mg/mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
45963-734-54459630734541 VIAL, GLASS in 1 CARTON (45963-734-54) / 1 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2c806400-5fdc-4398-8475-37f700b3191f
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=45963-734

Use it

Look up 45963-734 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45963-734 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45963-734. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.